Showing results (281-290 of 602) with videos related to
Sort By:
Pageof 61
Cell Transplantation|January 13, 2015
The role of brain-derived neurotrophic factor in bone marrow stromal cell-mediated spinal cord repairGaby J Ritfeld, Ajay Patel, Alexander Chou, et al.The Journal of Clinical Endocrinology and Metabolism|January 29, 2009
Increased hypothalamic-pituitary-adrenal axis activity in Huntington's diseaseN Ahmad Aziz, Hanno Pijl, Marijke Frölich, et al.Clinical Endocrinology|June 25, 2009
Leptin secretion rate increases with higher CAG repeat number in Huntington's disease patientsN Ahmad Aziz, Hanno Pijl, Marijke Frölich, et al.Parkinsonism & Related Disorders|August 14, 2009
The benefits of a standardized patient education program for patients with Parkinson's disease and their caregiversL E I A'Campo, E M Wekking, N G A Spliethoff-Kamminga, et al.Nuclear Medicine Communications|August 1, 1994
Clinical screening of monoclonal antibodies 323/A3, cSF-25 and K928 for suitability of targetting tumours in the upper aerodigestive and respiratory tractR De Bree, J C Roos, J J Quak, et al.Parkinsonism & Related Disorders|November 13, 2017
Grey matter volume loss is associated with specific clinical motor signs in Huntington's diseaseEmma M Coppen, Milou Jacobs, Annette A van den Berg-Huysmans, et al.Journal of Huntington'S Disease|February 1, 2021
Predictors of Working Capacity Changes Related to Huntington's Disease: A Longitudinal StudyKasper F van der Zwaan, Milou Jacobs, Erik W van Zwet, et al.Journal of Neurology|December 12, 2024
Cognitive impairment predicts medication discrepancies in Huntington's Disease: patient self-report compared to pharmacy recordsStephanie Feleus, Mai-Ly T D Vo, Laura C M Kuijper, et al.International Journal of Cancer|April 21, 1995
Tumor uptake of intravenously administered radiolabeled antibodies in ovarian carcinoma patients in relation to antigen expression and other tumor characteristicsM R Buist, P Kenemans, C F Molthoff, et al.International Journal of Radiation Oncology, Biology, Physics|August 1, 1996
Absorbed dose distribution of the auger emitters 67GA and 125I and the beta-emitters 67CU, 90Y, 131I, and 186RE as a function of tumor size, uptake, and intracellular distributionE B van Dieren, M A Plaizier, A van Lingen, et al.Pageof 61